Polymorphic variants of xenobiotic metabolism genes and body mass index in schizophrenia patients receiving antipsychotic therapy
https://doi.org/10.31363/2313-7053-2019-4-1-115-117
Abstract
The use of atypical antipsychotic drugs has made metabolic disorders one of the most common side effect of pharmacotherapy for schizophrenic patients. The aim of this study was to assess the contribution of polymorphic variants of genes of the P450 cytochrome system to changes in body mass index in patients with schizophrenia. As a result of the study, we did not identify significant associations of genotypes and alleles of the studied polymorphic variants of the CYP2D6, CYP1A2, CYP2C19 genes with weight gain in patients with schizophrenia of Russian nationality of the Siberian region receiving antipsychotic therapy and can revealed neither protective nor predisposing effects. Metabolic syndrome and, increase in body weight especially, are complex side effect, and further studies is needed to increase successful exploration and identification of the genetic component and assess contribution.
About the Authors
I. V. Pozhidaev
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
A. S. Boiko
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
E. G. Kornetova
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
References
1. Dubrovskaya VV, Kornetova EG, Semke AV, Ivanova SA, Arganik MB, Golovaha NE Clinical dynamics and social adaptation in patients with schizophrenia with following metabolic syndrome. Sovr. Ther. Psych. Dis. 2019;2:17-21 (In Russ.). DOI: 10.21265/ PSYPH.2019.24.20.003;
2. Mosolov SN et al. Metabolic side effects in modern antipsychotic pharmacotheraphy. Soc. and Clin. Pscyh. 2008;18(3):75–90 (In Russ.).
3. Casey DE, Zorn SH The pharmacology of weight gain with antipsychotics. J. Clin. Psychiatry. 2001;62(7):4–10;
4. Lau S et al. Predicting Weight Gain in Patients Treated With Clozapine. Journal of Clinical Psychopharmacology. 2016;36(2):120–124
5. Zhang JP et al. Pharmacogenetic Associations of Antipsychotic Drug–Related Weight Gain: A Systematic Review and Meta–analysis. Schizophrenia bulletin. 2016;42(6):1418-1437.
Review
For citations:
Pozhidaev I.V., Boiko A.S., Kornetova E.G. Polymorphic variants of xenobiotic metabolism genes and body mass index in schizophrenia patients receiving antipsychotic therapy. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2019;(4-1):115-117. (In Russ.) https://doi.org/10.31363/2313-7053-2019-4-1-115-117
Views:
520
Email this article 